| Ytd | -53.69% | |
| 1y | -49.33% |
| Open | 5.61 | Prev Close | 5.53 | Low | 5.35 | High | 6.10 | Mkt Cap | 133.06M |
| Vol | 160.97K | Avg Vol | 268.75K | EPS | -3.21 | P/E | -1.89 | Forward P/E | N/A |
| Beta | 3.93 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 4.88 | 200-d Avg | 8.95 | 1yr Est | 0.00 |
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aardvark Therapeutics (NASDAQ:AARD)
Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark
Top Wall Street analysts changed outlook on top names. DA Davidson initiated coverage on EBC & U
Top analysts changed outlook on top names. See all rating changes on analyst ratings page. Check out
Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings
Stocks fall in US, Dow drops 150 points. Energy sector up, consumer discretionary down. ISM and S&a
AMTD Digital Inc - ADR (NYSE: HKD) jumped 24.4% in pre-market trading after reporting a 565.7% incre